Updated
Corcept TherapeuticsCORT · Healthcare
$72.77+1.59%
Market cap$8.0B
IndustryBiotechnology

Corcept Therapeutics (CORT) Superinvestor holders

12 of the superinvestors we track hold Corcept Therapeutics (CORT) in their latest 13F filings, $869M in total.

Summary

The largest holder is Jim Simons (Renaissance Technologies), with $457M, 0.6% of the portfolio.

In their latest quarter: 4 added, 7 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Jim Simons
Renaissance Technologies
Trimmed 5,261,628$457M 0.6%Q2 2026
Cliff Asness
AQR Capital Management
Added 2,582,561$225M 0.1%Q2 2026
David Shaw
D. E. Shaw & Co.
Trimmed 883,001$77M 0.1%Q2 2026
Two Sigma
Two Sigma Investments
Trimmed 610,078$53M 0.0%Q2 2026
Chuck Royce
Royce Investment Partners
Trimmed 132,800$15M 0.1%Q3 2026
Acadian
Acadian Asset Management
Added 125,481$14M 0.0%Q3 2026
Eddie Brown
Brown Capital Management
Held 84,041$10M 1.8%Q3 2026
Man Group
Man Group plc
Trimmed 71,491$6M 0.0%Q2 2026
Joel Greenblatt
Gotham Asset Management
Added 60,181$5M 0.0%Q2 2026
Ray Dalio
Bridgewater Associates
Added 57,602$5M 0.0%Q2 2026
Paul Marshall
Marshall Wace
Trimmed 5,628$489,354 0.0%Q2 2026
Ensign Peak
Ensign Peak Advisors
Trimmed 5,089$442,489 0.0%Q2 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 202612
Q1 202617
Q4 202516
Q3 202517
Q2 202515
Q1 202514
Q4 202416
Q3 202414

Questions about Corcept Therapeutics

Which superinvestors own Corcept Therapeutics?

12 of the superinvestors we track hold Corcept Therapeutics (CORT) in their latest 13F filings, $869M in total. Jim Simons, Cliff Asness, David Shaw, Two Sigma, Chuck Royce, Acadian.

Who is the largest superinvestor holder of CORT?

The largest holder is Jim Simons (Renaissance Technologies), with $457M, 0.6% of the portfolio.

From Corcept Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Corcept Therapeutics and thousands of other companies, in one place. Free to start.